Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes

Clin Infect Dis. 2016 Apr 1;62(7):927-8. doi: 10.1093/cid/civ1227. Epub 2016 Jan 6.

Authors

Marianne Martinello¹, Gregory J Dore¹

Affiliation

¹ Kirby Institute, University of New South Wales Australia, Sydney, Australia.

PMID: 26743092
DOI: 10.1093/cid/civ1227

No abstract available

Keywords: HCV–HIV coinfection; direct-acting antiviral; real world.

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents / therapeutic use
Coinfection / drug therapy
Drug Therapy, Combination
HIV Infections / drug therapy
Hepacivirus
Hepatitis C / drug therapy*
Hepatitis C, Chronic / drug therapy
Humans
Interferons / therapeutic use*
Ribavirin / therapeutic use
Treatment Outcome

Substances

Antiviral Agents
Ribavirin
Interferons